CD274 and breast carcinoma: The objective of this study was to determine the landscape of PD-L1 protein expression in breast cancer using the DAKO 22C3 assay and to compare PD-L1–positive and PD-L1–negative cancers by comprehensive genomic profiling to determine if these populations differ in clinical or genomic characteristics.